TRPM2 and gastric cancer: Almasi et al. also found that the TRPM2 expression level is negatively correlated with the survival rate of patients with GC, which suggests that the application of TRPM2 targeting combined with chemotherapeutic drugs may be used as a strategy to improve current therapeutic effects and to improve the prognosis of patients with GC [144].